Impact Partnership Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Sell
10,400
-20,422
-66% -$544K 0.04% 278
2025
Q4
$767K Buy
30,822
+6,823
+28% +$172K 0.1% 138
2025
Q3
$611K Buy
+23,999
New +$592K 0.09% 139
2024
Q2
Sell
-882
Closed -$24.5K 541
2024
Q1
$24.5K Sell
882
-905
-51% -$25.1K 0.01% 372
2023
Q4
$51.5K Sell
1,787
-19,392
-92% -$586K 0.02% 319
2023
Q3
$703K Buy
21,179
+12,754
+151% +$451K 0.22% 51
2023
Q2
$309K Buy
+8,425
New +$328K 0.11% 137

Other funds holding PFE

Impact Partnership Wealth's PFE Position: Q1 2026 in Review

Impact Partnership Wealth reduced its Pfizer (PFE) stake by 66% in Q1 2026, selling an estimated $544K and leaving 10,400 shares worth $292K. The position accounts for 0.04% of the portfolio, ranked #278.

Impact Partnership Wealth first reported a position in PFE in Q2 2023 and has held it in 7 quarters since. The position peaked at $767K in Q4 2025. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Impact Partnership Wealth held 10,400 shares of Pfizer worth $292K as of Q1 2026.
  • Impact Partnership Wealth sold 20,422 Pfizer shares in Q1 2026, an estimated $544K.
  • Pfizer made up 0.04% of Impact Partnership Wealth's portfolio in Q1 2026, its #278 holding.
  • Impact Partnership Wealth first reported a position in Pfizer in Q2 2023 and has held it in 7 quarters since.
  • Impact Partnership Wealth's Pfizer position peaked at $767K in Q4 2025.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.